Etanercept
Based on 15 publication(s) in Google Scholar
Etanercept, a dimeric fusion protein that binds TNF, acts as a TNF inhibitor. Etanercept competitively inhibits the binding of both TNF-α and TNF-β to cell surface TNF receptors, rendering TNF biologically inactive. Etanercept shows efficacy against rheumatoid arthritis, juvenile idiopathic arthritis, and plaque psoriasis.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Pureté: 99.20%
- CAS No.: 185243-69-0
- Masse moléculaire:102.5 kDa
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications Citing Use of MedChemExpress (MCE) Etanercept
More- Bone Res. 2024 May 23;12(1):31. [Abstract]
- Int J Oral Sci. 2026 Mar 1;18(1):22. [Abstract]
- Genes Dis. 2022 Jun 20;10(4):1552-1563. [Abstract]
- J Neuroinflammation. 2025 Nov 1;22(1):256. [Abstract]
- Cell Rep. 2025 Feb 18;44(2):115287. [Abstract]
- JCI Insight. 2025 Nov 24;10(22):e190836. [Abstract]
- World J Stem Cells. 2022 Nov 26;14(11):798-814. [Abstract]
- iScience. 2024 Apr 26;27(6):109798. [Abstract]
- Clin Exp Immunol. 2023 Dec 11;214(1):120-129. [Abstract]
- J Pharm Biomed Anal. 2026 Mar 15:270:117273. [Abstract]
- Psychopharmacology (Berl). 2025 Oct 24. [Abstract]
- J Pain Res. 2025 Nov 12:18:6057-6063. [Abstract]
- Scand J Immunol. 2025 May;101(5):e70033. [Abstract]
- bioRxiv. 2025 Sep 12.
- SSRN. 2023 Nov 28.
-
In Vivo Efficacy Study
-
In Vivo Imaging
-
Histological Imaging/Staining
-
In Vivo Efficacy Study
-
IF
Voir tous les produits spécifiques à Isoform TNF Receptor
More
Activité biologique
|
Fas |
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Six-week-old male Lewis rats (adjuvant-induced arthritis (AIA) model)[4]
-
Dosage:10 mg/kg
-
Administration:S.c.; every 3 days for 3 weeks
-
Result:Significantly decreased the mean arthritis scores; Significant decreased in radiological score at the end of the treatment period.
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | Plexxikon| | 2011-05 | PHASE1 |
Unconjugated
The product can be reconstituted/diluted with sterile PBS or saline.
-
[TNFRSF1B (tumor necrosis factor receptor (TNFR)superfamily member 1B, TNFBR, p75, CD120b)]2-IGHG1 Fc (Fragment constant)
ELISA, FACS, Functional assay
-
Immobilized TNF-alpha/TNFSF2 Protein, Human (His, HY-P7416) can bind Etanercept. The EC50 for this effect is 9.44 ng/mL.
Chemical Information
-
CAS No. 185243-69-0
-
Appearance Liquid
-
Masse moléculaire 102.5 kDa
-
Color Colorless to light yellow
-
SMILES
[Etanercept]
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications (15)
-
Journal Impact Factor
-
Most Recent
-
Bone Res
Gut microbial metabolite targets HDAC3-FOXK1-interferon axis in fibroblast-like synoviocytes to ameliorate rheumatoid arthritis. [Abstract]2024 May 23;12(1):31. PMID: 38782893
Etanercept purchased from MedChemExpress. Usage Cited in: Bone Res. 2024 May 23;12(1):31. [Abstract]
Evaluation of arthritis scores for non-immunized (NI) mice or CIA mice in different treatment groups. Etanercept (i.p., 5 mg/kg) twice every week for 5 weeks.
Etanercept purchased from MedChemExpress. Usage Cited in: Bone Res. 2024 May 23;12(1):31. [Abstract]
Representative micro-CT images of the mice in different groups. Etanercept (i.p., 5 mg/kg) twice every week for 5 weeks.
Etanercept purchased from MedChemExpress. Usage Cited in: Bone Res. 2024 May 23;12(1):31. [Abstract]
Images of H&E and SafO-FG staining of the paw sections. Etanercept (i.p., 5 mg/kg) twice every week for 5 weeks.
Etanercept purchased from MedChemExpress. Usage Cited in: Bone Res. 2024 May 23;12(1):31. [Abstract]
Measurement of BS/BV, and quantification of synovial inflammation and bone erosion on H&E-stained sections, as well as cartilage erosion on SafO-FG-stained sections. Etanercept (i.p., 5 mg/kg) twice every week for 5 weeks.
Etanercept purchased from MedChemExpress. Usage Cited in: Bone Res. 2024 May 23;12(1):31. [Abstract]
Immunofluorescence staining of FOXK1, STAT1, STAT2, IL-6, IL-1β and MMP3 on sections of paws of the mice in different groups. Etanercept (i.p., 5 mg/kg) twice every week for 5 weeks.
-
Int J Oral Sci
Single-cell transcriptional atlas reveals distinct immune-chondrocyte crosstalk mechanisms in temporomandibular joint osteoarthritis induced by different types of occlusal disorder. [Abstract]2026 Mar 1;18(1):22. PMID: 41764220 -
Genes Dis
Protective effects of IRG1/itaconate on acute colitis through the inhibition of gasdermins-mediated pyroptosis and inflammation response. [Abstract]2022 Jun 20;10(4):1552-1563. PMID: 37397544 -
J Neuroinflammation
Inflammation associated microglial expansion disrupts hippocampal glial network communication, driving postoperative neurocognitive impairment. [Abstract]2025 Nov 1;22(1):256. PMID: 41176600 -
Cell Rep
Glycolytic reprogramming shapes the histone acetylation profile of activated CD4+ T cells in juvenile idiopathic arthritis. [Abstract]2025 Feb 18;44(2):115287. PMID: 40009514 -
JCI Insight
TNF-α represses fibroblast to myofibroblast transition through the histone methyltransferase Setdb2. [Abstract]2025 Nov 24;10(22):e190836. PMID: 41277557 -
World J Stem Cells
Tumor necrosis factor-α inhibition restores matrix formation by human adipose-derived stem cells in the late stage of chondrogenic differentiation. [Abstract]2022 Nov 26;14(11):798-814. PMID: 36483847 -
iScience
GSK2334470 attenuates high salt-exacerbated rheumatoid arthritis progression by restoring Th17/Treg homeostasis. [Abstract]2024 Apr 26;27(6):109798. PMID: 38947509 -
Clin Exp Immunol
NRF1 knockdown alleviates lipopolysaccharide-induced pulmonary inflammatory injury by upregulating DKK3 and inhibiting the GSK-3β/β-catenin pathway. [Abstract]2023 Dec 11;214(1):120-129. PMID: 37402316 -
J Pharm Biomed Anal
Leveraging digestion-assisted capillary electrophoresis sodium dodecyl sulfate (CE-SDS) to monitor galactosylation in monoclonal antibodies. [Abstract]2026 Mar 15:270:117273. PMID: 41275721 -
Psychopharmacology (Berl)
Agmatine ameliorates morphine-induced behavioral sensitization through blood-brain barrier protection and anti-neuroinflammatory effects in the nucleus accumbens. [Abstract]2025 Oct 24. PMID: 41134339 -
J Pain Res
2025 Nov 12:18:6057-6063. PMID: 41257213 -
Scand J Immunol
The Fusion Protein MuSK-Fc Functions as a Decoy to Block the Binding of Anti-MuSK Antibodies to MuSK. [Abstract]2025 May;101(5):e70033. PMID: 40411208 -
-
Pureté et documentation
-
Fiche technique (261 KB)
-
SDS (419 KB)
- English - EN (419 KB)
- Français - FR (419 KB)
- Deutsch - DE (419 KB)
- Norwegian - NO (419 KB)
- Español - ES (419 KB)
- Swedish - SV (419 KB)
- Italian - IT (419 KB)
- Korean - KR (419 KB)
- Portuguese - PT (419 KB)
-
Inhibitory Antibodies User Guide (603 KB)
Références
[1]. Goffe B, et al. Etanercept: An overview. J Am Acad Dermatol. 2003;49(2 Suppl):S105-S111. [Content Brief]
[2]. Goldenberg MM. Etanercept, a novel drug for the treatment of patients with severe, active rheumatoid arthritis. Clin Ther. 1999;21(1):75-2. [Content Brief]
[3]. Haraoui B, et al. Etanercept in the treatment of rheumatoid arthritis. Ther Clin Risk Manag. 2007;3(1):99-105. [Content Brief]
[4]. Totoson P, et al. Etanercept improves endothelial function via pleiotropic effects in rat adjuvant-induced arthritis. Rheumatology (Oxford). 2016;55(7):1308-1317. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)